Literature DB >> 19112565

Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables.

Edoardo Rosato1, Stefania Maione, Antonio Vitarelli, Anna Giunta, Luca Fontanella, Laura Tanturri de Horatio, Francesco Cacciatore, Michele Proietti, Simonetta Pisarri, Felice Salsano.   

Abstract

The incidence of left ventricular (LV) diastolic dysfunction is increased in systemic sclerosis (SSc), while systolic dysfunction is present in a small percentage of patients. The aim of this study was to asses the LV "regional" diastolic abnormalities in SSc patients by the mean of Doppler tissue imaging (DTI). Echocardiographic echo-Doppler (DE) and DTI parameters were analyzed for 67 SSc patients: abnormal E/A ratio at DE was detected in 24, while abnormal e/a at DTI was observed in 41. A significant prevalence of DTI diastolic abnormalities in the segments reflecting longitudinal versus those reflecting radial LV motion was found. The segments of the basal regions of LV myocardium were significantly more involved than those of the middle portion. Linear correlation was observed between the extent of the diastolic abnormalities and the duration of disease. Longitudinal myocardial systolic velocities were significantly reduced in patients with abnormal e/a DTI.

Entities:  

Mesh:

Year:  2008        PMID: 19112565     DOI: 10.1007/s00296-008-0827-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  33 in total

1.  Myocardial architecture, texture and left ventricular heterogeneity in the pulsed Doppler tissue imaging pattern.

Authors:  J Coucelo; J Azevedo; A Felizardo; L Soares; J Pereira; A Mota; A Coelho; H Custódio; I Arroja
Journal:  Rev Port Cardiol       Date:  2000-02       Impact factor: 1.374

2.  Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement.

Authors:  K Nakajima; J Taki; M Kawano; T Higuchi; S Sato; C Nishijima; K Takehara; N Tonami
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

3.  Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function.

Authors:  D Pellerin; R Sharma; P Elliott; C Veyrat
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

4.  Echocardiographic identification of cardiac abnormality in scleroderma and related disorders.

Authors:  J S Gottdiener; H M Moutsopoulos; J L Decker
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

5.  Ultrasonic videodensitometric analysis in scleroderma heart disease.

Authors:  V Di Bello; C Ferri; D Giorgi; M Bianchi; A Bertini; A Martini; F A Storino; M Paterni; G Pasero; C Giusti
Journal:  Coron Artery Dis       Date:  1999       Impact factor: 1.439

6.  Left ventricular diastolic function in systemic sclerosis.

Authors:  G Aguglia; A Sgreccia; M L Bernardo; E Carmenini; M Giusti De Marle; A Reali; S Morelli
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

7.  Quantitative Doppler tissue imaging of the left ventricular myocardium: validation in normal subjects.

Authors:  C L Donovan; W F Armstrong; D S Bach
Journal:  Am Heart J       Date:  1995-07       Impact factor: 4.749

8.  Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension.

Authors:  A Giunta; E Tirri; S Maione; S Cangianiello; A Mele; A De Luca; G Valentini
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

9.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

Authors:  W P Follansbee; T R Miller; E I Curtiss; J E Orie; R L Bernstein; J M Kiernan; T A Medsger
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

10.  Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma.

Authors:  R J Siegel; B O'Connor; I Mena; J M Criley
Journal:  Am Heart J       Date:  1984-12       Impact factor: 4.749

View more
  5 in total

1.  Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Hariklia Dimitroula; Tilemahos Sfetsios; Despina Parcharidou; Haralambos Karvounis; Loukas Settas
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

Review 2.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

3.  Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.

Authors:  Antonietta Gigante; Giuseppe Barilaro; Biagio Barbano; Antonella Romaniello; Francesca Di Mario; Silvia Quarta; Maria Ludovica Gasperini; Gianluca Di Lazzaro Giraldi; Alessandro Laviano; Antonio Amoroso; Rosario Cianci; Edoardo Rosato
Journal:  Cardiorenal Med       Date:  2016-01-23       Impact factor: 2.041

4.  Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis.

Authors:  Monique Hinchcliff; Chintan S Desai; John Varga; Sanjiv J Shah
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

5.  Role of 2D strain in the early identification of left ventricular dysfunction and in the risk stratification of systemic sclerosis patients.

Authors:  Maurizio Cusmà Piccione; Concetta Zito; Gianluca Bagnato; Giuseppe Oreto; Gianluca Di Bella; Gianfilippo Bagnato; Scipione Carerj
Journal:  Cardiovasc Ultrasound       Date:  2013-02-03       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.